• 1
    Bleyer A, Albritton KH, Ries LAG, Barr RD. Introduction. In: BleyerA, BarrRD, eds. Cancer in Adolescents and Young Adults. Berlin: Springer-Verlag; 2007: 7-15.
  • 2
    Canadian Cancer Society's Steering Committee. Canadian Cancer Statistics 2009. Special Topic: Cancer in Adolescents and Young Adults. Toronto, Ontario, Canada: Canadian Cancer Society; 2009: 82-83.
  • 3
    Pollock BH, Krischer JP, Vietti TJ. Interval between symptom onset and diagnosis of pediatric solid tumors. J Pediatr. 1991; 119: 725-732.
  • 4
    Collins SR, Schoen C, Kriss JL, Doty MM, Mahato B. Rite of passage? Why young adults become uninsured and how new policies can help. Issue Brief (Commonw Fund). 2006; 20: 1-14.
  • 5
    Ziv A, Boulet JR, Slap GB. Utilization of physician offices by adolescents in the United States. Pediatrics. 1999; 104( 1 pt 1): 35-42.
  • 6
    Gonzalez-Hermoso F, Perez-Palma J, Marchena-Gomez J, Lorenzo-Rocha N, Medina-Arana V. Can early diagnosis of symptomatic colorectal cancer improve the prognosis? World J Surg. 2004; 28: 716-720.
  • 7
    Richards MA, Westcombe AM, Love SB, Littlejohns P, Ramirez AJ. Influence of delay on survival in patients with breast cancer: a systematic review. Lancet. 1999; 353: 1119-1126.
  • 8
    Albritton KH, Wiggins CH, Nelson HE, Weeks JC. Site of oncologic specialty care for older adolescents in Utah. J Clin Oncol. 2007; 25: 4616-4621.
  • 9
    Klein-Geltink J, Shaw AK, Morrison HI, Barr RD, Greenberg ML. Use of paediatric versus adult oncology treatment centres by adolescents 15-19 years old: the Canadian Childhood Cancer Surveillance and Control Program. Eur J Cancer. 2005; 41: 404-410.
  • 10
    Roush SW, Krischer JP, Cox MW, Pollock BH. Socioeconomic and demographic factors that predict where children receive cancer care in Florida. J Clin Epidemiol. 1993; 46: 535-544.
  • 11
    Brady AM, Harvey C. The practice patterns of adult oncologists' care of pediatric oncology patients. Cancer. 1993; 71 ( 10 suppl): 3237-3240.
  • 12
    Bleyer A, Budd T, Montello M. Adolescents and young adults with cancer: the scope of the problem and criticality of clinical trials. Cancer. 2006; 107 ( 7 suppl): 1645-1655.
  • 13
    Peppercorn JM, Weeks JC, Cook EF, Joffe S. Comparison of outcomes in cancer patients treated within and outside clinical trials: conceptual framework and structured review. Lancet. 2004; 363: 263-270.
  • 14
    van Hoff J, Schymura MJ, Curnen MG. Trends in the incidence of childhood and adolescent cancer in Connecticut, 1935-1979. Med Pediatr Oncol. 1988; 16: 78-87.
  • 15
    Albritton KH, Bleyer A. The management of cancer in the older adolescent. Eur J Cancer. 2003; 39: 2584-2599.
  • 16
    Greenberg ML, Barr RD, DiMonte B, McLaughlin E, Greenberg C. Childhood cancer registries in Ontario, Canada: lessons learned from a comparison of two registries. Int J Cancer. 2003; 105: 88-91.
  • 17
    Bleyer WA, Tejeda H, Murphy SB, et al. National cancer clinical trials: children have equal access; adolescents do not. J Adolesc Health. 1997; 21: 366-373.
  • 18
    Stock W, La M, Sanford B, et al. What determines the outcomes for adolescents and young adults with acute lymphoblastic leukemia treated on cooperative group protocols? A comparison of Children's Cancer Group and Cancer and Leukemia Group B studies. Blood. 2008; 112: 1646-1654.
  • 19
    Barry E, DeAngelo DJ, Neuberg D, et al. Favorable outcome for adolescents with acute lymphoblastic leukemia treated on Dana-Farber Cancer Institute Acute Lymphoblastic Leukemia Consortium Protocols. J Clin Oncol. 2007; 25: 813-819.
  • 20
    Boissel N, Auclerc MF, Lheritier V, et al. Should adolescents with acute lymphoblastic leukemia be treated as old children or young adults? Comparison of the French FRALLE-93 and LALA-94 trials. J Clin Oncol. 2003; 21: 774-780.
  • 21
    Kantarjian HM, O'Brien S, Smith TL, et al. Results of treatment with hyper-CVAD, a dose-intensive regimen, in adult acute lymphocytic leukemia. J Clin Oncol. 2000; 18: 547-561.
  • 22
    Gupta AA, Pappo A, Saunders N, et al. Clinical outcome of children and adults with localized Ewing sarcoma: impact of chemotherapy dose and timing of local therapy. Cancer. 2010; 116: 3189-3194.
  • 23
    Sinkovics JG, Plager C, Ayala AG, Lindberg RD, Samuels ML. Ewing sarcoma: its course and treatment in 50 adult patients. Oncology. 1980; 37: 114-119.
  • 24
    Siegel RD, Ryan LM, Antman KH. Adults with Ewing's sarcoma. An analysis of 16 patients at the Dana-Farber Cancer Institute. Am J Clin Oncol. 1988; 11: 614-617.
  • 25
    Verrill MW, Judson IR, Wiltshaw E, Thomas JM, Harmer CL, Fisher C. The use of paediatric chemotherapy protocols at full dose is both a rational and feasible treatment strategy in adults with Ewing's family tumours. Ann Oncol. 1997; 8: 1099-1105.
  • 26
    Bacci G, Ferrari S, Comandone A, et al. Neoadjuvant chemotherapy for Ewing's sarcoma of bone in patients older than thirty-nine years. Acta Oncol. 2000; 39: 111-116.
  • 27
    Pieper S, Ranft A, Braun-Munzinger G, Jurgens H, Paulussen M, Dirksen U. Ewing's tumors over the age of 40: a retrospective analysis of 47 patients treated according to the International Clinical Trials EICESS 92 and EURO-E.W.I.N.G. 99. Onkologie. 2008; 31: 657-663.
  • 28
    Bleyer A. The Quid Pro Quo of pediatric versus adult services for older adolescent cancer patients. Pediatr Blood Cancer. 2010; 54: 238-241.
  • 29
    Niewerth D, Creutzig U, Bierings MB, Kaspers GJ. A review on allogeneic stem cell transplantation for newly diagnosed pediatric acute myeloid leukemia. Blood. 2010; 116: 2205-2214.
  • 30
    Nachman JB, La MK, Hunger SP, et al. Young adults with acute lymphoblastic leukemia have an excellent outcome with chemotherapy alone and benefit from intensive postinduction treatment: a report from the children's oncology group. J Clin Oncol. 2009; 27: 5189-5194.